| Post |
| Pre |
| LA |
|---|
| 3.8 |
| 2.2 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 1 | - | 3 | 8.5 | 115.8 | 13.2 | - | - | - | 141.5 |
| - | 0.3 | - | - | - | 18.8 | 1.8 | - | - | - | 20.8 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 11.2 |
| 2.8 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 8.8 |
| 1.8 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 539 | 74.3% | -2.70 | 83 | 52.5% |
| Optic-unspecified(L) | 91 | 12.6% | -0.92 | 48 | 30.4% |
| AME(L) | 45 | 6.2% | -2.03 | 11 | 7.0% |
| CentralBrain-unspecified | 35 | 4.8% | -2.32 | 7 | 4.4% |
| LA(L) | 15 | 2.1% | -0.74 | 9 | 5.7% |
| upstream partner | # | NT | conns Lat3 | % In | CV |
|---|---|---|---|---|---|
| aMe17a (L) | 1 | unc | 20.8 | 12.3% | 0.0 |
| MeVP45 (L) | 1 | ACh | 13.5 | 8.0% | 0.0 |
| Cm34 (L) | 1 | Glu | 13 | 7.7% | 0.0 |
| aMe26 (L) | 3 | ACh | 11.8 | 6.9% | 0.1 |
| MeVC3 (R) | 1 | ACh | 11.5 | 6.8% | 0.0 |
| aMe12 (L) | 4 | ACh | 6.8 | 4.0% | 0.5 |
| Lat3 (L) | 4 | unc | 6.8 | 4.0% | 0.4 |
| Mi10 (L) | 16 | ACh | 6 | 3.5% | 0.5 |
| Cm31b (L) | 1 | GABA | 4.8 | 2.8% | 0.0 |
| Mi15 (L) | 10 | ACh | 4.2 | 2.5% | 0.6 |
| aMe2 (L) | 4 | Glu | 3.8 | 2.2% | 0.7 |
| Cm24 (L) | 4 | Glu | 3.2 | 1.9% | 0.8 |
| MeVC20 (L) | 2 | Glu | 3.2 | 1.9% | 0.1 |
| aMe17b (L) | 3 | GABA | 3 | 1.8% | 0.6 |
| MeTu1 (L) | 10 | ACh | 3 | 1.8% | 0.3 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 2.8 | 1.6% | 0.6 |
| MeVP1 (L) | 6 | ACh | 2.5 | 1.5% | 0.7 |
| Cm20 (L) | 4 | GABA | 2.5 | 1.5% | 0.6 |
| Cm1 (L) | 7 | ACh | 2.5 | 1.5% | 0.3 |
| MeVP33 (L) | 1 | ACh | 2.2 | 1.3% | 0.0 |
| CL125 (L) | 2 | Glu | 2.2 | 1.3% | 0.8 |
| Cm3 (L) | 6 | GABA | 2.2 | 1.3% | 0.5 |
| Cm8 (L) | 5 | GABA | 2 | 1.2% | 0.8 |
| Dm8a (L) | 7 | Glu | 2 | 1.2% | 0.3 |
| OA-AL2i3 (L) | 2 | OA | 1.8 | 1.0% | 0.7 |
| MeVC27 (R) | 3 | unc | 1.8 | 1.0% | 0.4 |
| C2 (L) | 1 | GABA | 1.2 | 0.7% | 0.0 |
| aMe5 (L) | 5 | ACh | 1.2 | 0.7% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| Dm9 (L) | 2 | Glu | 1 | 0.6% | 0.5 |
| Dm-DRA1 (L) | 2 | Glu | 1 | 0.6% | 0.5 |
| OA-AL2i4 (L) | 1 | OA | 1 | 0.6% | 0.0 |
| MeVP8 (L) | 2 | ACh | 1 | 0.6% | 0.5 |
| Cm5 (L) | 3 | GABA | 1 | 0.6% | 0.4 |
| Cm21 (L) | 3 | GABA | 1 | 0.6% | 0.4 |
| Cm6 (L) | 3 | GABA | 1 | 0.6% | 0.4 |
| MeVPMe5 (R) | 3 | Glu | 1 | 0.6% | 0.4 |
| aMe22 (L) | 1 | Glu | 0.8 | 0.4% | 0.0 |
| Lat4 (L) | 1 | unc | 0.8 | 0.4% | 0.0 |
| Dm20 (L) | 1 | Glu | 0.8 | 0.4% | 0.0 |
| Cm17 (L) | 1 | GABA | 0.8 | 0.4% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.8 | 0.4% | 0.0 |
| aMe6b (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Cm28 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| MeVC7a (R) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Dm2 (L) | 2 | ACh | 0.5 | 0.3% | 0.0 |
| ME_unclear (L) | 2 | Glu | 0.5 | 0.3% | 0.0 |
| aMe15 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Cm12 (L) | 2 | GABA | 0.5 | 0.3% | 0.0 |
| MeTu3c (L) | 2 | ACh | 0.5 | 0.3% | 0.0 |
| aMe30 (L) | 2 | Glu | 0.5 | 0.3% | 0.0 |
| HBeyelet (L) | 2 | HA | 0.5 | 0.3% | 0.0 |
| Cm10 (L) | 2 | GABA | 0.5 | 0.3% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.5 | 0.3% | 0.0 |
| DNc01 (R) | 1 | unc | 0.2 | 0.1% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Lat2 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| Tm37 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| aMe1 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm9 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm14 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Dm8b (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP10 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVC24 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| TmY17 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPMe9 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| aMe9 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Cm16 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| R8d | 1 | HA | 0.2 | 0.1% | 0.0 |
| MeVPMe9 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| aMe8 (L) | 1 | unc | 0.2 | 0.1% | 0.0 |
| aMe9 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP59 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVC5 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Cm30 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVP36 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVC6 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Lat3 | % Out | CV |
|---|---|---|---|---|---|
| Lat3 (L) | 4 | unc | 6.8 | 10.5% | 0.4 |
| aMe10 (L) | 1 | ACh | 2.8 | 4.3% | 0.0 |
| Cm9 (L) | 8 | Glu | 2.8 | 4.3% | 0.5 |
| Cm8 (L) | 8 | GABA | 2.8 | 4.3% | 0.4 |
| Cm3 (L) | 9 | GABA | 2.5 | 3.9% | 0.3 |
| MeTu1 (L) | 8 | ACh | 2.5 | 3.9% | 0.3 |
| Cm34 (L) | 1 | Glu | 2.2 | 3.5% | 0.0 |
| MeVP45 (L) | 1 | ACh | 1.8 | 2.7% | 0.0 |
| Cm23 (L) | 3 | Glu | 1.8 | 2.7% | 0.4 |
| Tm5c (L) | 6 | Glu | 1.8 | 2.7% | 0.3 |
| aMe5 (L) | 4 | ACh | 1.5 | 2.3% | 0.6 |
| MeVPMe11 (L) | 1 | Glu | 1.2 | 2.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 1.2 | 2.0% | 0.0 |
| Cm5 (L) | 4 | GABA | 1.2 | 2.0% | 0.3 |
| MeTu3c (L) | 3 | ACh | 1.2 | 2.0% | 0.3 |
| aMe26 (L) | 2 | ACh | 1.2 | 2.0% | 0.6 |
| Cm21 (L) | 2 | GABA | 1 | 1.6% | 0.0 |
| Cm11c (L) | 3 | ACh | 1 | 1.6% | 0.4 |
| MeVPMe5 (L) | 3 | Glu | 1 | 1.6% | 0.4 |
| Mi15 (L) | 4 | ACh | 1 | 1.6% | 0.0 |
| Cm24 (L) | 4 | Glu | 1 | 1.6% | 0.0 |
| Lat2 (L) | 2 | unc | 1 | 1.6% | 0.5 |
| aMe4 (L) | 4 | ACh | 1 | 1.6% | 0.0 |
| C2 (L) | 1 | GABA | 0.8 | 1.2% | 0.0 |
| MeVP7 (L) | 2 | ACh | 0.8 | 1.2% | 0.3 |
| Cm20 (L) | 2 | GABA | 0.8 | 1.2% | 0.3 |
| L1 (L) | 3 | Glu | 0.8 | 1.2% | 0.0 |
| MeVP59 (L) | 1 | ACh | 0.5 | 0.8% | 0.0 |
| Cm29 (L) | 1 | GABA | 0.5 | 0.8% | 0.0 |
| Cm16 (L) | 1 | Glu | 0.5 | 0.8% | 0.0 |
| MeVPMe9 (R) | 1 | Glu | 0.5 | 0.8% | 0.0 |
| L4 (L) | 1 | ACh | 0.5 | 0.8% | 0.0 |
| L2 (L) | 1 | ACh | 0.5 | 0.8% | 0.0 |
| MeVC8 (R) | 1 | ACh | 0.5 | 0.8% | 0.0 |
| MeTu3b (L) | 2 | ACh | 0.5 | 0.8% | 0.0 |
| MeVC27 (R) | 2 | unc | 0.5 | 0.8% | 0.0 |
| aMe2 (L) | 2 | Glu | 0.5 | 0.8% | 0.0 |
| aMe1 (L) | 1 | GABA | 0.5 | 0.8% | 0.0 |
| MeVPMe10 (L) | 1 | Glu | 0.5 | 0.8% | 0.0 |
| aMe17c (L) | 2 | Glu | 0.5 | 0.8% | 0.0 |
| Cm10 (L) | 2 | GABA | 0.5 | 0.8% | 0.0 |
| MeTu4a (L) | 2 | ACh | 0.5 | 0.8% | 0.0 |
| Cm7 (L) | 2 | Glu | 0.5 | 0.8% | 0.0 |
| aMe12 (L) | 2 | ACh | 0.5 | 0.8% | 0.0 |
| R8d | 2 | HA | 0.5 | 0.8% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| Cm1 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Tm36 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Cm25 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVP62 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| aMe3 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| aMe15 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| Cm33 (L) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| Dm2 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Tm37 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| 5thsLNv_LNd6 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| DN1a (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| MeVPMe2 (R) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Tm35 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVP14 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| TmY9b (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| T1 (L) | 1 | HA | 0.2 | 0.4% | 0.0 |
| Tm5b (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Cm15 (L) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| MeVP6 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVP34 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| MeTu2b (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| MeVP21 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVP49 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 0.2 | 0.4% | 0.0 |
| DNp27 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| R7d | 1 | HA | 0.2 | 0.4% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| MeVP10 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |
| Cm14 (L) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| MeVPMe5 (R) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| LT58 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 0.2 | 0.4% | 0.0 |